Gold ingots in Russia. Photographer: Andrey Rudakov/BloomberggettyAs someone who’s been involved in capital markets his entire adult life, I can safely say that gold investors haven’t seen a period like this in decades. The third quarter of 2025 was nothing short of historic, and in many ways, I believe we’re witnessing the beginning of a new era for the yellow metal.According to the World Gold Council (WGC), global demand reached 1,313 metric tons in Q3, the highest quarterly figure ever recorded. In dolla ...

Shopify is a leading, Canada-based company that enables online and brick-and-mortar commerce. (Photo by Sean Gallup/Getty Images)Getty ImagesInvestors often gravitate toward Shopify as the marquee name in e-commerce software, but it’s not the only compelling option in the space. Another player—AppLovin (APP)—has been quietly strengthening its fundamentals and expanding its reach, even as Shopify continues to command a premium valuation. With both companies operating in the broader application software ecosy ...

Core Viewpoint - Accenture (ACN) stock is considered a solid value buy, currently trading below average valuation while experiencing modest growth and maintaining strong margins [2][3]. Valuation and Performance - ACN is down 30% this year but is 37% less expensive based on its Price-to-Sales (P/S) ratio compared to one year ago, and its Price-to-Earnings (P/E) ratio is below the S&P 500 median [4]. - The stock's discounted valuation reflects market hesitance regarding IT spending recovery and initial investor concerns about AI's impact, despite Accenture's proactive technology investments [5]. Financial Fundamentals - Accenture's Q4 fiscal 2025 adjusted operating margin stands at 15.1%, supported by a strong pipeline of high-value AI and cloud transformation projects [5]. - The company has a revenue growth rate of 7.4% over the last twelve months and an average operating margin of approximately 14.4% over the past three years [11]. Investment Strategy - Investing in stocks with low valuations and strong margins allows for potential mean reversion and valuation re-rating, with lower downside risk due to the ability of high-margin companies to sustain earnings [3]. - ACN's fundamentals include a P/E multiple of 19.9, which is considered modest despite encouraging financial metrics [11]. Future Outlook - Accenture's $3 billion multi-year investment in AI is projected to triple FY25 GenAI revenue to $2.7 billion and nearly double bookings to $5.9 billion [5]. - The average forward returns for stocks like ACN are 12.7% for 6 months and 25.8% for 12 months, with a win rate greater than 70% for positive returns in both periods [12].

Core Viewpoint - PayPal has been adjusting to post-pandemic realities, resulting in a stock valuation significantly below historical averages, with revenue growth slowing and increased competition in the digital payments sector, yet the stock is approaching a technical support zone that has historically indicated potential recoveries [2][4] Group 1: Stock Performance and Valuation - PayPal stock is currently trading within a support zone of $59.67 to $65.95, a level where it has previously seen significant rebounds, averaging a peak return of 83.2% on six occasions over the past decade [3] - The stock trades at a price-to-earnings (PE) multiple of 12.1, indicating a notable valuation discount compared to industry peers [4][9] Group 2: Financial Performance and Strategic Initiatives - PayPal's Q3 2025 results exceeded earnings and revenue expectations, leading to an increased full-year EPS forecast, alongside the introduction of a dividend and aggressive share repurchase initiatives, reflecting financial discipline [4] - Strategic developments include a $7 billion loan transaction with Blue Owl in the Buy Now Pay Later (BNPL) space, AI collaborations, and strong growth in Venmo, aligning with digital payment trends [4] Group 3: Financial Metrics - PayPal has reported a revenue growth of 4.5% over the last twelve months and an average of 6.7% over the last three years [9] - The company has a free cash flow margin of approximately 16.9% and an operating margin of 19.2% for the last twelve months [9]

Oracle stock dropped -29% in the previous month. You may feel inclined to increase your investment, or you might consider decreasing your exposure. However, there is a completely different viewpoint you could be overlooking. Is there a superior alternative? It appears that its counterpart, Adobe, offers more.SAN FRANCISCO, CA - OCTOBER 22: Oracle co-founder and Chairman Larry Ellison delivers a keynote address during the Oracle OpenWorld on October 22, 2018 in San Francisco, California. The Oracle co-founde ...

ANKARA, TURKIYE - AUGUST 26: In this photo illustration Google logo is being displayed on a mobile phone screen, in front of Meta logo in Ankara, Turkiye, on August 26, 2025. (Photo by Harun Ozalp /Anadolu via Getty Images)Anadolu via Getty ImagesDespite Alphabet’s stock (NASDAQ: GOOGL) climbing 45% this year compared to only a 2% gain for Meta Platforms’ stock (NASDAQ: META), a deeper analysis of their fundamentals suggests a potential opportunity.META, a key competitor to Alphabet, currently trades at a l ...

Group 1 - Broadcom's stock surged over 100% in the past year, driven by a 28% revenue growth and a 190% increase in net margin, despite a 45% decrease in the P/E multiple [2][3] - The rally is attributed to AI-related growth, a strategic acquisition, and positive analyst sentiment [2][3] - Key factors include a surge in AI semiconductor revenue, successful integration of VMware, strong earnings, innovative AI product launches, and favorable analyst ratings [9] Group 2 - AI semiconductor revenue growth was fueled by custom accelerators and networking solutions [9] - The integration of VMware enhanced infrastructure software revenue and created synergies [9] - Analysts have maintained Buy ratings and increased price targets, reflecting confidence in Broadcom's AI future [9]

ToplineNovo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced a deal with the pharmaceutical firms to reduce the U.S. price tag of the popular drugs. Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.Copyright 2023 The Associated Press. All rights reserved.Key FactsThe out-of-pocket monthly pric ...

Markets are bracing for Wednesday, when Nvidia will report earnings. (Photo by Justin Sullivan/Getty Images)Getty ImagesKey TakeawaysKey Earnings And Fed Minutes May Drive Significant Midweek Market VolatilityNvidia’s Report Looms Large Amid AI Bubble Concerns And Stretched ValuationsFalling Rate-Cut Odds Pressure Bonds, Equities, And Broader Market SentimentIt was a mixed week for markets with the S&P 500 clinging to a 0.1% gain and the Nasdaq Composite falling 0.5%. As I mentioned last week, there are thr ...

Twist Bioscience logo on modern office building facade with glass and metal exterior, South San Francisco, California, October 16, 2025. (Photo by Smith Collection/Gado/Getty Images)Gado via Getty ImagesTwist Bioscience (TWST) stock has decreased by 10.1% in one day. The recent downturn signifies renewed worries regarding wider-than-anticipated losses and ambiguous profitability guidance, but significant drops like this often prompt a more challenging question: is this weakness merely temporary, or does it ...